跳至主要内容
临床试验/CTRI/2023/06/054028
CTRI/2023/06/054028尚未招募2 期

Clinical evaluation of Sanjivani vati and Pippaladyasava in the management of Agnimandya - a randomized parallel group study

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex with age between 18 and 60 years.
  • 2.Patients having any six sign and symptoms of Agnimandya out of 10 (below
  • mentioned) along with reduced Abhyavaharan Shakti, (capacity to eat), Jarana
  • Shakti (capacity to digest), and Ruchi (appetite) for the past one week.
  • 3 Udaragaurava
  • 4 Shirorogaurava
  • 9 Gatrasada
  • 10 Malavarodha
  • 3.Willing to participate in the study.

排除标准

  • 1.Patients of age <18 years and >60 years.
  • 2.Patients in whom Agnimandya is caused due to intake of medicine.
  • 3.Patients having Tikshagni (hyper functioning of digestion and metabolic
  • activities), and Samagni (moderate Agni)
  • 4.Patients having any established disease of Gastro-intestinal tracts.
  • 5.Immuno-compromised states and patients with systemic infections or known cases
  • of AIDS, HIV, STD etc.
  • 6.Patients with severe/history of cardiac, hepatic, cerebro-vascular disease,
  • pulmonary dysfunction, malignancy, chronic uncontrolled systemic diseases or
  • renal disorder (S. Creatinine >1.2 mg/dl) etc or poorly controlled Hypertension
  • (Blood pressure more than 160/100mm of Hg), uncontrolled Diabetes Mellitus
  • (HbA1c>=8), or any other serious medical illness.
  • 7.Patients on medication with corticosteroids or any other drugs that may have an
  • influence on the outcome of the study.
  • 8.History of hypersensitivity to the trial drug or any of its ingredients.
  • 9.Patients who have completed participation in any other clinical trial during the
  • past three months.
  • 10.Any other condition, which the Investigator thinks, may jeopardize the study.

研究者

相似试验